{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 3731, "factors": [{"GSM562809": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "KMM-1"}}, {"GSM562810": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "KMS-11"}}, {"GSM5628": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS", "CELL LINE": "KMS-12-PE"}}, {"GSM562812": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS", "CELL LINE": "KMS-12-BM"}}, {"GSM562813": {"CULTURING MEDIUM": "IMDM, 10% FBS", "CELL LINE": "lp-1"}}, {"GSM562814": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "MM1S"}}, {"GSM562815": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "MOLP-2"}}, {"GSM562816": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS", "CELL LINE": "MOLP-8"}}, {"GSM562817": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS, 2 mM L-glutamine, 1 mM sodium-pyrovate", "CELL LINE": "NCI-H929"}}, {"GSM562818": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "OPM-2"}}, {"GSM562819": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "RPMI-8226"}}, {"GSM562820": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS, 5 \u03bcM melphalan was added once a week", "CELL LINE": "RPMI-8226 LR5"}}, {"GSM56282": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "U-266"}}, {"GSM562822": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS", "CELL LINE": "AMO-1"}}, {"GSM562823": {"CULTURING MEDIUM": "RPMI-1640, 20% FBS", "CELL LINE": "DB"}}, {"GSM562824": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "HT"}}, {"GSM562825": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "OCI-Ly7"}}, {"GSM562826": {"CULTURING MEDIUM": "RPMI-1640, 10% FBS", "CELL LINE": "SU-DHL-4"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "A predictive gene list for response to high dose melphalan therapy in patients diagnosed with multiple myeloma is generated by combining...", "pubmed_id": 21559449, "geo_gse_id": "E-GEOD-22759", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 2, "sample_count": 18, "tags": ["cell", "line", "median", "multiple myeloma", "myeloma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "expression-data-from-cell-lines-originating-from-p", "geo_id_plat": "E-GEOD-22759_A-AFFY-44", "name": "Expression data from cell lines originating from patients with multiple myeloma, plasmacytoma and diffuse large B-cell lymphoma", "created": "Sep.15, 2014", "summary": "A predictive gene list for response to high dose melphalan therapy in patients diagnosed with multiple myeloma is generated by combining results from dose response experiments and microarray data using a B-cell line panel and the introduction of multivariate regression techniques. 18 malignant B-cell lines were analyzed by gene expression microarrays and screened for melphalan median dose dependent growth inhibition. Results are used to build a predictive gene list for response to high dose melphalan therapy in multiple myeloma.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22759", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22759/samples/"}